![Tomer Berkovitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tomer Berkovitz
Directeur/Membre du Conseil chez
SOPHIA GENETICS SA
Profil
Tomer Berkovitz is currently an Independent Non-Executive Director at SOPHiA GENETICS SA since 2021, a Director at PrognomIQ, Inc. since 2020, and Managing Partner at aMoon Ventures Y Sh Ltd. since 2023.
Former positions include Director at Zebra Medical Vision Ltd. from 2018 to 2021, Chief Operating & Financial Officer at Alcobra Ltd. from 2014 to 2018, Executive Director in the Investment Banking Division at JPMorgan Chase Bank, NA (New York), Director at Mapi-Pharma Ltd., and General Partner at aMoon Fund.
Education includes undergraduate and graduate degrees from Tel-Aviv University and a doctorate from Columbia Business School.
Postes actifs de Tomer Berkovitz
| Sociétés | Poste | Début |
|---|---|---|
| SOPHIA GENETICS SA | Directeur/Membre du Conseil | 01/03/2021 |
aMoon Ventures Y Sh Ltd.
 aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focus on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor. | Private Equity Investor | 01/02/2018 |
PrognomIQ, Inc.
 PrognomIQ, Inc. Medical SpecialtiesHealth Technology Develops and commercializes multi-omics human tests for cancer and other diseases | Directeur/Membre du Conseil | 15/09/2020 |
Anciens postes connus de Tomer Berkovitz
| Sociétés | Poste | Fin |
|---|---|---|
Zebra Medical Vision Ltd.
 Zebra Medical Vision Ltd. Packaged SoftwareTechnology Services Provides a medical imaging research platform services | Directeur/Membre du Conseil | 30/11/2021 |
Alcobra Ltd.
 Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary pharmaceutical products | Directeur Financier/CFO | 01/01/2018 |
aMoon Fund
 aMoon Fund Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | - |
| MAPI PHARMA LTD | Directeur/Membre du Conseil | - |
JPMorgan Chase Bank, NA (New York)
 JPMorgan Chase Bank, NA (New York) Major BanksFinance Operates as an national bank that provides consumer and commercial banking services | Corporate Officer/Principal | - |
Formation de Tomer Berkovitz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
26
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary pharmaceutical products | Health Technology |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
JPMorgan Chase Bank, NA (New York)
JPMorgan Chase Bank, NA (New York) Major BanksFinance Operates as an national bank that provides consumer and commercial banking services | Finance |
Mapi-Pharma Ltd.
 Mapi-Pharma Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of generic drugs that include complex active pharmaceutical ingredients, formulations and life cycle management products | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SOPHiA GENETICS SA
 SOPHiA GENETICS SA Packaged SoftwareTechnology Services Develops software services for healthcare industry | Technology Services |
Zebra Medical Vision Ltd.
Zebra Medical Vision Ltd. Packaged SoftwareTechnology Services Provides a medical imaging research platform services | Technology Services |
aMoon Ventures Y Sh Ltd.
aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focus on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor. | Finance |
aMoon Fund
aMoon Fund Investment ManagersFinance Acts as Venture Capital Fund | Finance |
PrognomIQ, Inc.
PrognomIQ, Inc. Medical SpecialtiesHealth Technology Develops and commercializes multi-omics human tests for cancer and other diseases | Health Technology |
